Paul Chaplin
Inventor
Stats
- 28 total patents issued
- 58 total patents filed
- most recent filing
This is official USPTO record data
Details
- 28 Issued Patents
- 58 Filed Patents
- 275 Total Citation Count
- Aug 17, 2012 Most Recent Filing
- Apr 18, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| BAVARIAN NORDIC A/S | 4 4 4 5 3 5 3 14 3 | 2003 2005 2006 2007 2008 2009 2010 2011 2012 |
Inventor Addresses
| Address | Duration |
|---|---|
| GRAFELFING, DE | Nov 01, 12 - Dec 27, 12 |
| Grafelfing, DE | May 31, 12 - Jul 19, 12 |
| München, DE | Mar 10, 09 - Dec 04, 12 |
| MUNCHEN, DE | Jul 22, 10 - Dec 15, 11 |
| MUNICH, DE | Sep 08, 11 - Sep 08, 11 |
| Mucnchen, DE | Feb 25, 10 - Feb 25, 10 |
| Munchen, DE | Nov 24, 05 - May 03, 12 |
| Munich, DE | Jul 13, 04 - Feb 12, 13 |
| US | - |
Technology Profile
| Technology | # of Patents | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 5 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 43 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 16 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 8,372,622 | 2013 | Modified vaccinia virus ankara for the vaccination of neonates | 0 |
| 2012/0328,650 | 2012 | MODIFIED VACCINIA ANKARA VIRUS VARIANT | 0 |
| 8,323,661 | 2012 | Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | 0 |
| 8,309,098 | 2012 | Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs) | 0 |
| 2012/0276,613 | 2012 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD | 0 |
